Anticorps Recombinant de lapin anti-CD30/TNFRSF8

CD30/TNFRSF8 Recombinant Antibody for Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Conjugaison

Non conjugué

CloneNo.

241331E12

N° de cat : 84241-4-PBS

Synonymes

CD30, 241331E12, Ki 1 antigen, Ki 1, D1S166E

---

Galerie de données de validation

• 

  Sandwich ELISA standard curve of MP01137-1

  Sandwich ELISA standard curve of MP01137-1, Human CD30/TNFRSF8 Recombinant Matched Antibody Pair - PBS only. 84241-2-PBS was coated to a plate as the capture antibody and incubated with serial dilutions of standard RP02334. 84241-4-PBS was HRP conjugated as the detection antibody. Range: 39.1-1250 pg/mL.

• 

  Sample test of MP01137-1

  Serum of six individual healthy human donors was measured. The CD30/TNFRSF8 concentration of detected samples was determined to be 1,639.1 pg/mL with a range of 1,021.2-2,597.7 pg/mL.

• 

  Cytometric bead array standard curve of MP01137-1

  Cytometric bead array standard curve of MP01137-1, TNFRSF8/CD30 Recombinant Matched Antibody Pair, PBS Only. Capture antibody: 84241-2-PBS. Detection antibody: 84241-4-PBS. Standard: RP02334. Range: 0.313-40 ng/mL.

---

Informations sur le produit

84241-4-PBS cible CD30/TNFRSF8 dans les applications de Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: Protéine recombinante
• Nom complet: tumor necrosis factor receptor superfamily, member 8
• Masse moléculaire calculée: 64 kDa
• Numéro d’acquisition GenBank: NM_001243
• Symbole du gène: CD30
• Identification du gène (NCBI): 943
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

{{ptg:RelatedPrimaryAntibodies}}